Dr. Christopher Smith

Dr. Christopher Smith
Dr. Smith attended Indiana University and the University of Louisville where he graduated cum laude. In 1992 he graduated from the University of Louisville School of Medicine and trained at the University Hospitals, completing his urological surgery training in 1997. He joined Kentucky Urological Associates out of residency with a clinical appointment at the University of Louisville. Dr. Smith has had extensive postgraduate training in laparoscopic urology and was the first to perform retroperitoneal laparoscopic kidney, adrenal surgery and the pre-peritoneal prostatectomy in greater Louisville. Dr. Smith has also performed bench and clinical research on neurogenic bladder. Currently a clinical professor of urologic surgery at the University of Louisville, Dr. Smith remains active in teaching students and residents. He is a member of numerous local, regional and national societies, including the Society of Laparoscopic Surgeons. Dr. Smith has considerable experience in office treatments for BPH, and his interests include laparoscopic urologic surgery, percutaneous stone surgery and minimally invasive BPH treatments.
Medical School:

University of Louisville

Residency:

University of Louisville

Locations

First Urology Louisville, Kentucky

3920 Dupont Square South, Suite CLouisville, Kentucky, 40207United States
502.897.7172 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only